Clinical Trial Update: Fibrinogen Concentrate (Human) - Efficacy and Safety Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of human fibrinogen concentrate for afibrinogenemia and hypofibrinogenemia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Afibrinogenemia
• Fibrinogen Deficiency
• Hypofibrinogenemia

Drugs mentioned

• Fibrinogen Concentrate (Human) (fibrinogen concentrate)

Snippet

Sponsor: CSL Behring | Conditions: Afibrinogenemia, Hypofibrinogenemia | Phase 3 | Status: WITHDRAWN